Article Versions Notes

Rammensee H-G, Gouttefangeas C, Heidu S, Klein R, Preuß B, Walz JS, Nelde A, Haen SP, Reth M, Yang J, et al. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups. Vaccines. 2021; 9(5):428. https://doi.org/10.3390/vaccines9050428

Rammensee, Hans-Georg, Cécile Gouttefangeas, Sonja Heidu, Reinhild Klein, Beate Preuß, Juliane Sarah Walz, Annika Nelde, Sebastian P. Haen, Michael Reth, Jianying Yang, and et al. 2021. "Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups" Vaccines 9, no. 5: 428. https://doi.org/10.3390/vaccines9050428

Rammensee, H.-G., Gouttefangeas, C., Heidu, S., Klein, R., Preuß, B., Walz, J. S., Nelde, A., Haen, S. P., Reth, M., Yang, J., Tabatabai, G., Bösmüller, H., Hoffmann, H., Schindler, M., Planz, O., Wiesmüller, K.-H., & Löffler, M. W. (2021). Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups. Vaccines, 9(5), 428. https://doi.org/10.3390/vaccines9050428